486 related articles for article (PubMed ID: 28094851)
21. Blood transfusion for preventing stroke in people with sickle cell disease.
Riddington C; Wang W
Cochrane Database Syst Rev; 2002; (1):CD003146. PubMed ID: 11869654
[TBL] [Abstract][Full Text] [Related]
22. Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia.
Geneen LJ; Dorée C; Estcourt LJ
Cochrane Database Syst Rev; 2023 Mar; 3(3):CD012349. PubMed ID: 36877640
[TBL] [Abstract][Full Text] [Related]
23. Transfusion of red blood cells stored for shorter versus longer duration for all conditions.
Shah A; Brunskill SJ; Desborough MJ; Doree C; Trivella M; Stanworth SJ
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD010801. PubMed ID: 30578732
[TBL] [Abstract][Full Text] [Related]
24. Folate supplementation in people with sickle cell disease.
Dixit R; Nettem S; Madan SS; Soe HHK; Abas AB; Vance LD; Stover PJ
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD011130. PubMed ID: 29546732
[TBL] [Abstract][Full Text] [Related]
25. Magnesium for treating sickle cell disease.
Than NN; Soe HHK; Palaniappan SK; Abas AB; De Franceschi L
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD011358. PubMed ID: 31498421
[TBL] [Abstract][Full Text] [Related]
26. Vitamin D supplementation for sickle cell disease.
Soe HH; Abas AB; Than NN; Ni H; Singh J; Said AR; Osunkwo I
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010858. PubMed ID: 28105733
[TBL] [Abstract][Full Text] [Related]
27. Folate supplementation in people with sickle cell disease.
Dixit R; Nettem S; Madan SS; Soe HH; Abas AB; Vance LD; Stover PJ
Cochrane Database Syst Rev; 2016 Feb; 2():CD011130. PubMed ID: 26880182
[TBL] [Abstract][Full Text] [Related]
28. Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support.
Estcourt LJ; Malouf R; Trivella M; Fergusson DA; Hopewell S; Murphy MF
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD011305. PubMed ID: 28128441
[TBL] [Abstract][Full Text] [Related]
29. Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support.
Radford M; Estcourt LJ; Sirotich E; Pitre T; Britto J; Watson M; Brunskill SJ; Fergusson DA; Dorée C; Arnold DM
Cochrane Database Syst Rev; 2024 May; 5(5):CD011305. PubMed ID: 38780066
[TBL] [Abstract][Full Text] [Related]
30. Pathogen-reduced platelets for the prevention of bleeding.
Estcourt LJ; Malouf R; Hopewell S; Trivella M; Doree C; Stanworth SJ; Murphy MF
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD009072. PubMed ID: 28756627
[TBL] [Abstract][Full Text] [Related]
31. Deferasirox for managing transfusional iron overload in people with sickle cell disease.
Meerpohl JJ; Antes G; Rücker G; Fleeman N; Niemeyer C; Bassler D
Cochrane Database Syst Rev; 2010 Aug; (8):CD007477. PubMed ID: 20687088
[TBL] [Abstract][Full Text] [Related]
32. Magnesium for treating sickle cell disease.
Than NN; Soe HHK; Palaniappan SK; Abas AB; De Franceschi L
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011358. PubMed ID: 28409830
[TBL] [Abstract][Full Text] [Related]
33. Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia.
Fisher SA; Brunskill SJ; Doree C; Gooding S; Chowdhury O; Roberts DJ
Cochrane Database Syst Rev; 2013 Aug; (8):CD004450. PubMed ID: 23963793
[TBL] [Abstract][Full Text] [Related]
34. Hydroxyurea for primary stroke prevention in children with sickle cell anaemia in Nigeria (SPRING): a double-blind, multicentre, randomised, phase 3 trial.
Abdullahi SU; Jibir BW; Bello-Manga H; Gambo S; Inuwa H; Tijjani AG; Idris N; Galadanci A; Hikima MS; Galadanci N; Borodo A; Tabari AM; Haliru L; Suleiman A; Ibrahim J; Greene BC; Ghafuri DL; Rodeghier M; Slaughter JC; Kirkham FJ; Neville K; Kassim A; Trevathan E; Jordan LC; Aliyu MH; DeBaun MR
Lancet Haematol; 2022 Jan; 9(1):e26-e37. PubMed ID: 34971579
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological interventions for painful sickle cell vaso-occlusive crises in adults.
Cooper TE; Hambleton IR; Ballas SK; Johnston BA; Wiffen PJ
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31742673
[TBL] [Abstract][Full Text] [Related]
36. Interventions for hereditary haemochromatosis: an attempted network meta-analysis.
Buzzetti E; Kalafateli M; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011647. PubMed ID: 28273330
[TBL] [Abstract][Full Text] [Related]
37. Long-term results using hydroxyurea/phlebotomy for reducing secondary stroke risk in children with sickle cell anemia and iron overload.
Greenway A; Ware RE; Thornburg CD
Am J Hematol; 2011 Apr; 86(4):357-61. PubMed ID: 21442640
[TBL] [Abstract][Full Text] [Related]
38. Drugs for preventing red blood cell dehydration in people with sickle cell disease.
Nagalla S; Ballas SK
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD003426. PubMed ID: 30338520
[TBL] [Abstract][Full Text] [Related]
39. Interventions for patients and caregivers to improve knowledge of sickle cell disease and recognition of its related complications.
Asnani MR; Quimby KR; Bennett NR; Francis DK
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD011175. PubMed ID: 27711980
[TBL] [Abstract][Full Text] [Related]
40. Red blood cell transfusion for people undergoing hip fracture surgery.
Brunskill SJ; Millette SL; Shokoohi A; Pulford EC; Doree C; Murphy MF; Stanworth S
Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD009699. PubMed ID: 25897628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
